Ann: $3 million Oversubscribed Placement Completed, page-14

First 14 Last

Share
Profile

Follow
Bull Whisperer

3,047 Posts.

182

24/06/21

19:53

Post #: 54053766
Share

Originally posted by SCJH: ↑

I recently recieved an email from the compay (current CEO) about market related questions.

I have asked about 7 questions and It was pretty standard reply, no clear answers. However he said the last CR was very important for the company for its future and over the comming weeks and months company could address my questions.

He reiterated that they are expecting assays results over the comming weeks and JORC update will be followed in due course.

Side topic but this is my pesronal opinion and the reason why JL took the CTO is that he needed to focus on the future projects, especially the role that he can maixmise his talents and experties and time.

Remember we just officialised JV, tanked with cash and we are in very early stage at Kookynie also we have Yundamindra which we havent started to drill yet. He also said that the company is continuing to developing of the JV.

I probably top up my last portion in this week and my total $ invest on MCT will close to 100k. There are no money that is okay to lose so I really hope this sp is bottom...

All in my opinion and do your own research.

This forum is grate and dont get me wrong but most of info in here is biased by experience, objectives or emotions etc. So I strongly recommend you to contact the company if you have a questions / feedback, then the company may feel to improve their communications.

Cheers!

Expand

Is this scenario following same result of last lot of assays pending and awaiting some other positive announcement to help to rectify any due results is this following a pattern?

MCT Price at posting: 1.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 48 more messages in this thread...

First 14 Last

Add MCT (ASX) to my watchlist

Ann: $3 million Oversubscribed Placement Completed, page-14

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News